Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine if combination therapy with rosiglitazone and
bexarotene might have a synergistic effect in the treatment of patients with CTCL.
Phase:
Phase 2
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center